Wijkstrom Joakim
SEC CIK 1785888 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | SVP, CMO | 333.5K | — | $593.7K | 13 | 2021-08-20 | 2026-03-02 |
Most active insiders at VNDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | — | $1.28M |
| 2 | Moran Kevin Patrick | SVP, CFO, Treas | — | $351.0K |
| 3 | Williams Timothy | SVP, GC | — | $350.9K |
| 4 | Birznieks Gunther | SVP, Business Development | — | $350.9K |
| 5 | Wijkstrom Joakim | SVP, CMO | — | $254.7K |
| 6 | Honore Tage | Dir | — | $240.9K |
| 7 | McGuire Daniel Patrick | SVP, GC, Sec | — | — |
| 8 | Duncan Charles Cliff | Dir | — | — |
| 9 | Mitchell Stephen Ray | Dir | — | — |
| 10 | Ward Anne Sempowski | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | S - Sale | $8.27 | -30.8K | 333.5K | -8% | -$254.7K | |
| 2026-02-19 | 2026-02-18 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | A - Grant | $0.00 | +125.0K | 364.3K | +52% | $0 | |
| 2025-03-04 | 2025-03-01 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | F - Tax | $4.76 | -15.5K | 239.3K | -6% | -$73.9K | |
| 2025-02-20 | 2025-02-18 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | A - Grant | $0.00 | +125.0K | 254.8K | +96% | $0 | |
| M | 2024-03-06 | 2024-03-04+ | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | S - Sale | $4.30 | -16.7K | 129.8K | -11% | -$71.9K |
| 2024-02-21 | 2024-02-16 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | A - Grant | $0.00 | +32.7K | 146.5K | +29% | $0 | |
| 2023-08-23 | 2023-08-21 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | S - Sale | $5.84 | -3,724 | 113.8K | -3% | -$21.7K | |
| M | 2023-03-06 | 2023-03-02+ | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | S - Sale | $6.26 | -11.8K | 117.5K | -9% | -$74.1K |
| D | 2023-02-21 | 2023-02-16 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | A - Grant | $0.00 | +32.7K | 129.4K | +34% | $0 |
| 2022-08-23 | 2022-08-22 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | S - Sale | $10.27 | -3,605 | 96.7K | -4% | -$37.0K | |
| D | 2022-03-02 | 2022-02-28 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | A - Grant | $0.00 | +32.7K | 107.3K | +44% | $0 |
| D | 2022-03-02 | 2022-03-02 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | S - Sale | $11.19 | -6,974 | 100.3K | -7% | -$78.0K |
| 2021-08-23 | 2021-08-20 | VNDA | Vanda Pharmaceuticals Inc. | Wijkstrom Joakim | SVP, CMO | S - Sale | $15.39 | -3,650 | 74.6K | -5% | -$56.2K |
Purchase Sale Sale after option exercise All abbreviations